Biosync Pharmaceuticals Private Limited

Biosync Pharmaceuticals Private Limited - pharma in Chandigarh, India. FY 2026 financials & compliance.
CIN U24232CH2008PTC031442 Incorporated 01 December 2008 ROC Chandigarh HQ Chandigarh, India
Active Private Limited Company pharma
Data last updated
Revenue · FY 2025
₹5.38 Cr
▼ 1% YoY
Net profit · FY 2025
₹14.95 Lakh
Net margin 2.8%
EBITDA · FY 2025
₹23.06 Lakh
EBITDA margin 4.3%
Authorised capital
₹5 Lakh
Registered with MCA
Paid-up capital
₹5 Lakh
Issued & subscribed
Company age
18 yrs
Est. 2008
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered

About Biosync Pharmaceuticals Private Limited

Data last updated:

Biosync Pharmaceuticals Private Limited is a private limited company based in Chandigarh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 01 December 2008 and has been in existence for over 18 years.

The company is registered with the Registrar of Companies (ROC), Chandigarh, under CIN U24232CH2008PTC031442. Its GSTIN is 04AADCB6307K1ZV (Chandigarh).

The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors Bharat Bhushan Singh and Komal Thakur.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Scf No 259 Motor Market Manimajra, Chandigarh, India – 160001.

As per the financials filed for FY 2025, the company reported a revenue of ₹5.38 Cr, a decline of 1% compared to the previous year. For the same year it recorded a net profit of ₹14.95 Lakh (net margin 2.8%) and EBITDA of ₹23.06 Lakh (EBITDA margin 4.3%). Revenue has grown at a compounded annual rate (CAGR) of 3% over three years and 1% over five years.

The company is associated with 3 brands: Biosync, Biohamllin Research Lab and Biosync Pharmaceuticals Pvt Ltd.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website biosyncpharma.in.

Company Details of Biosync Pharmaceuticals Private Limited
CIN U24232CH2008PTC031442
Registration Number 031442
Incorporation Date 01 December 2008
ROC Chandigarh
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Social Media
  • Registered Address
    Scf No 259 Motor Market Manimajra, Chandigarh, India – 160001
  • Industry
    Pharma, Drug Formulation & Development, Pharma Contract R&D
Comprehensive company report
Biosync Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
  • One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Unlock the full Biosync Pharmaceuticals Private Limited report

Financials, compliance, directors, charges, ownership and filings for Biosync Pharmaceuticals Private Limited in one report.

Financials from 2015 Directors & ownership Charges & compliance

Business Activity of Biosync Pharmaceuticals Private Limited

The main business activity of Biosync Pharmaceuticals is trade. In detail, this covers wholesale trading.

Main Activity Group CodeDescription of Main ActivityBusiness Activity CodeDescription of Business ActivityTurnover Percentage
GTradeG1Wholesale TradingLocked
Premium access

Business activity turnover details

Turnover share and past changes in activity are in the company report.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Financials of Biosync Pharmaceuticals Private Limited FY 2025 filings available

Biosync Pharmaceuticals Private Limited reported revenue of ₹5.38 Cr (down 1% YoY) for FY 2025.

Revenue · FY 2025
₹5.38 Cr ▼ 1%
Net profit · FY 2025
₹14.95 Lakh margin 2.8%
EBITDA · FY 2025
₹23.06 Lakh margin 4.3%

Compounded Annual Growth Rate (CAGR) of Biosync Pharmaceuticals Private Limited

Revenue CAGR growth
1 year
▼ 1%
3 years · compounded
▲ 3%
5 years · compounded
▲ 1%
EBITDA CAGR growth
1 year
▲ 11%
3 years · compounded
▼ 2%
5 years · compounded
▼ 4%

Revenue fell 1% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 1%. EBITDA rose 11% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary of Biosync Pharmaceuticals Private Limited

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations••••••••••••••••••••
Other Income••••••••••••••••••••
Total Revenue••••••••••••••••••••
Cost of Materials Consumed••••••••••••••••••••
Employee Benefit Expense••••••••••••••••••••
Finance Costs••••••••••••••••••••
Depreciation and Amortisation••••••••••••••••••••
Other Expenses••••••••••••••••••••
Total Expenses••••••••••••••••••••
EBITDA₹23.06 Lakh••••••••••••••••
Profit Before Tax••••••••••••••••••••
Tax Expense••••••••••••••••••••
Net Profit (PAT)₹14.95 Lakh••••••••••••••••
Balance Sheet
Share Capital••••••••••••••••••••
Reserves and Surplus••••••••••••••••••••
Net Worth (Total Equity)••••••••••••••••••••
Long-term Borrowings••••••••••••••••••••
Short-term Borrowings••••••••••••••••••••
Trade Payables••••••••••••••••••••
Total Liabilities••••••••••••••••••••
Fixed Assets••••••••••••••••••••
Investments••••••••••••••••••••
Inventories••••••••••••••••••••
Trade Receivables••••••••••••••••••••
Cash and Bank Balance••••••••••••••••••••
Total Assets••••••••••••••••••••

Financial Ratios of Biosync Pharmaceuticals Private Limited

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin4.3%••••••••••••••••
Net Profit Margin2.8%••••••••••••••••
Return on Equity (ROE)••••••••••••••••••••
Return on Capital Employed (ROCE)••••••••••••••••••••
Return on Assets (ROA)••••••••••••••••••••
Liquidity and Debt
Current Ratio••••••••••••••••••••
Quick Ratio••••••••••••••••••••
Debt-to-Equity Ratio••••••••••••••••••••
Interest Coverage Ratio••••••••••••••••••••
Efficiency and Growth
Asset Turnover••••••••••••••••••••
Receivable Days••••••••••••••••••••
Payable Days••••••••••••••••••••
Inventory Days••••••••••••••••••••
Revenue Growth••••••••••••••••••••
Net Profit Growth••••••••••••••••••••

Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Biosync Pharmaceuticals are in the company report.

Premium access

Financial statements from 2015

Earlier years and trend charts are in the company report.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Peer Comparison of Biosync Pharmaceuticals Private Limited

Biosync Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Contract Research, Formulations, Pharmaceuticals). Revenue, net profit, margin and growth of each company are in the company report.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Yati Pharmaceuticals Private Limited••••••••••••••••33Muzaffarnagar, Uttar Pradesh, India
Vatican Life Sciences Private Limited••••••••••••••••-Karnal, Haryana, India
Bvk's Bioscience Private Limited••••••••••••••••-Kalol, Gujarat, India
Firstmed Therapeutics Private Limited••••••••••••••••-Vanur Tk, Tamil Nadu, India
Makeway Formulations Private Limited••••••••••••••••44Bhubaneswar, Orissa, India
Biosync Pharmaceuticals Private Limited this company••••••••••••••••-Chandigarh, India
Macheal Laboratories Limited••••••••••••••••-Gujarat, India
Cardo Pharma Private Limited••••••••••••••••31Patna, Bihar, India
Upsilon Pharmaceuticals Health Care Private Limited••••••••••••••••-Gwalior, Madhya Pradesh, India
Jyoti Vishnu Pharma Private Limited••••••••••••••••-Hyderabad, Telangana, India
JPM Pharma & Chemicals Private Limited••••••••••••••••-Kandivali East, Maharashtra, India

Peers are the five companies nearest above and the five nearest below Biosync Pharmaceuticals by revenue in the Pharma industry (Contract Research, Formulations, Pharmaceuticals), from the latest filed financials of each company. Revenue, net profit, margin and growth of each peer are in the company report.

Auditor Details of Biosync Pharmaceuticals Private Limited

Biosync Pharmaceuticals Private Limited is audited by S P BABUTA & ASSOCIATES for the financial year 2021.

NameStatusAppointment DateCessation Date
S P BABUTA & ASSOCIATESLockedLockedLocked
Premium access

Complete auditor history

Appointment and cessation dates and past auditor changes are in the company report.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Board of Directors of Biosync Pharmaceuticals Private Limited

Biosync Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Bharat Bhushan SinghDirector01 Dec 200817 Years 10 MonthsCurrent
Komal ThakurDirector07 Feb 20251 Years 8 MonthsCurrent

Ownership and Shareholding of Biosync Pharmaceuticals Private Limited

Premium access

Shareholding and ownership data

Promoter, institutional, public and beneficial ownership figures are in the company report.

  • Ownership categories
  • Historical changes
  • Group structure
  • FII and DII holdings

Verified entity values are shown only after access is granted.

Charges & Borrowings of Biosync Pharmaceuticals Private Limited

Biosync Pharmaceuticals Private Limited does not have any charges (loans) registered with the Registrar of Companies.

Associated Brands with Biosync Pharmaceuticals Private Limited

Biosync Pharmaceuticals operates multiple associated brands including Biosync, Biohamllin Research Lab, and Biosync Pharmaceuticals Pvt Ltd. Each brand links to its own profile.

BrandDescriptionWebsite
Pharmaceutical manufacturing and franchise services in India.biosyncpharma.in
Pharmaceutical manufacturing, PCD franchise, and third-party services in India.biohamllin.com
Pharmaceutical manufacturing and franchise services are offered in India.murtelacosmetics.com

Employees and EPFO Compliance at Biosync Pharmaceuticals Private Limited

Employment history and EPFO contributions of people linked to Biosync Pharmaceuticals.

Premium access

Employee and EPFO history

Monthly headcount, contribution history and filing status are in the company report.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

Recent Activity on Biosync Pharmaceuticals Private Limited

Biosync Pharmaceuticals Private Limited has 3 board changes on record since 2008: 2 appointments and 1 cessation. The latest: Anurag Bhatia ceased to be Director on 24 Feb 2025.

AGM
Biosync Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Biosync Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Chandigarh.
Ceased
Anurag Bhatia ceased to be Director.
Appointed
Komal Thakur was appointed as Director.
Appointed
Bharat Bhushan Singh was appointed as Director.
Incorporation
01 Dec 2008
Biosync Pharmaceuticals Private Limited was registered on 01 Dec 2008 with Roc Chandigarh & aged 17 years 10 months as per MCA records.

Credit Ratings, Litigation & Regulatory Alerts for Biosync Pharmaceuticals Private Limited

Premium access

Credit ratings, litigation, and regulatory alerts

Credit ratings, court records and regulatory alerts are in the company report.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Biosync Pharmaceuticals Private Limited

Premium access

MSME payment history

Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Biosync Pharmaceuticals Private Limited

Premium access

Corporate group structure

Parent, subsidiary, associate and joint venture records with holdings are in the company report.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

GST Compliance of Biosync Pharmaceuticals Private Limited

Biosync Pharmaceuticals has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
04AADCB6307K1ZVChandigarhActive01 Jul 2017
Premium access

GST registrations and filing compliance

State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Biosync Pharmaceuticals Private Limited

Premium access

MCA filings and documents

Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Biosync Pharmaceuticals Private Limited

Biosync Pharmaceuticals is an active private limited company based in Chandigarh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 01 December 2008 (18+ years old) and is registered under CIN U24232CH2008PTC031442.

Biosync Pharmaceuticals reported revenue of ₹5.38 Cr for FY 2025 (down 1% YoY).

Biosync Pharmaceuticals has 2 current directors:

Biosync Pharmaceuticals reported a net profit of ₹14.95 Lakh (net margin 2.8%) and EBITDA of ₹23.06 Lakh (EBITDA margin 4.3%) for FY 2025, as per its filed financial statements.

The compounded annual growth rate (CAGR) of the revenue of Biosync Pharmaceuticals is 3% over three years and 1% over five years. In the latest year (FY 2025) revenue fell 1%. CAGR is the steady yearly rate that links the first and the last year.

The GSTIN of Biosync Pharmaceuticals is 04AADCB6307K1ZV, registered in Chandigarh.

The CIN (Corporate Identification Number) of Biosync Pharmaceuticals is U24232CH2008PTC031442. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Biosync Pharmaceuticals was incorporated on 01 December 2008, making it 18+ years old. It is registered with the Registrar of Companies, Chandigarh.

The peers of Biosync Pharmaceuticals by revenue are Yati Pharmaceuticals Private Limited, Vatican Life Sciences Private Limited, Bvk's Bioscience Private Limited, Firstmed Therapeutics Private Limited, Makeway Formulations Private Limited and 5 more, all in the Pharma industry (Contract Research, Formulations, Pharmaceuticals).

Anurag Bhatia ceased to be Director on 24 Feb 2025. Komal Thakur was appointed as Director on 07 Feb 2025. Bharat Bhushan Singh was appointed as Director on 01 Dec 2008.

Biosync Pharmaceuticals can be reached through the website biosyncpharma.in. Its registered office is in Chandigarh, India.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - compiled from official filings and updated regularly.

Subscription plans available